PMID- 26256882 OWN - NLM STAT- MEDLINE DCOM- 20151106 LR - 20191210 IS - 0485-1439 (Print) IS - 0485-1439 (Linking) VI - 56 IP - 6 DP - 2015 Jun TI - [Brentuximab vedotin and cord blood transplantation for primary refractory Hodgkin lymphoma following autologous hematopoietic stem cell transplantation]. PG - 699-704 LID - 10.11406/rinketsu.56.699 [doi] AB - We report a 26-year-old man with primary refractory nodular sclerosis Hodgkin lymphoma against ABVD, ICE and autologous peripheral blood stem cell transplantation (auto-PBSCT), presenting with multiple epidural spinal cord compressions, paraplegia, and generalized lymphadenopathy. We administrated four cycles of brentuximab vedotin to achieve a complete response, and then conducted cord blood transplantation. This case raises the possibility of a new strategy for refractory Hodgkin lymphoma showing residual lesions after auto-PBSCT. FAU - Meshitsuka, Sohsuke AU - Meshitsuka S AD - Department of Hematology, Japanese Red Cross Medical Center. FAU - Suzuki, Kenshi AU - Suzuki K FAU - Igeta, Yukifusa AU - Igeta Y FAU - Kawai, Sigeo AU - Kawai S FAU - Kumasaka, Toshio AU - Kumasaka T FAU - Tsukada, Nobuhiro AU - Tsukada N LA - jpn PT - Case Reports PT - Journal Article PL - Japan TA - Rinsho Ketsueki JT - [Rinsho ketsueki] The Japanese journal of clinical hematology JID - 2984782R RN - 0 (Immunoconjugates) RN - 7XL5ISS668 (Brentuximab Vedotin) SB - IM MH - Adult MH - Brentuximab Vedotin MH - Fetal Blood/*transplantation MH - Hematopoietic Stem Cell Transplantation MH - Hodgkin Disease/*therapy MH - Humans MH - Immunoconjugates/*therapeutic use MH - Male MH - Recurrence MH - Transplantation, Autologous MH - Treatment Outcome EDAT- 2015/08/11 06:00 MHDA- 2015/11/07 06:00 CRDT- 2015/08/11 06:00 PHST- 2015/08/11 06:00 [entrez] PHST- 2015/08/11 06:00 [pubmed] PHST- 2015/11/07 06:00 [medline] AID - 10.11406/rinketsu.56.699 [doi] PST - ppublish SO - Rinsho Ketsueki. 2015 Jun;56(6):699-704. doi: 10.11406/rinketsu.56.699.